Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
SUM1315MO2 Volasertib
0.0001
PLK
Cell cycle
0.9093 0.01247
SUM1315MO2 Volasertib
0.00031623
PLK
Cell cycle
1.0623 0.00166
SUM1315MO2 Volasertib
0.001
PLK
Cell cycle
0.9525 0.00450
SUM1315MO2 Volasertib
0.0031623
PLK
Cell cycle
0.9729 0.00939
SUM1315MO2 Volasertib
0.01
PLK
Cell cycle
0.4513 0.10657
SUM1315MO2 Volasertib
0.031623
PLK
Cell cycle
-0.2322 0.37882
SUM1315MO2 Volasertib
0.1
PLK
Cell cycle
-0.4082 0.51079
SUM1315MO2 Volasertib
0.31623
PLK
Cell cycle
-0.3877 0.52524
SUM1315MO2 Volasertib
1.0
PLK
Cell cycle
-0.3596 0.48717
SUM1315MO2 Dinaciclib
0.0001
pan CDK
Cell cycle
1.1110 0.00021
SUM1315MO2 Dinaciclib
0.00031623
pan CDK
Cell cycle
1.0028 -0.00350
SUM1315MO2 Dinaciclib
0.001
pan CDK
Cell cycle
1.0323 0.00457
SUM1315MO2 Dinaciclib
0.0031623
pan CDK
Cell cycle
0.9193 0.00975
SUM1315MO2 Dinaciclib
0.01
pan CDK
Cell cycle
0.6218 0.02693
SUM1315MO2 Dinaciclib
0.031623
pan CDK
Cell cycle
-0.6209 0.58097
SUM1315MO2 Dinaciclib
0.1
pan CDK
Cell cycle
-0.6422 0.63067
SUM1315MO2 Dinaciclib
0.31623
pan CDK
Cell cycle
-0.6615 0.63971
SUM1315MO2 Dinaciclib
1.0
pan CDK
Cell cycle
-0.6674 0.61233
SUM1315MO2 Cisplatin
0.0010833
Chemo
Chemotherapy
1.0113 -0.01160
SUM1315MO2 Cisplatin
0.0033333
Chemo
Chemotherapy
0.9009 0.00959
SUM1315MO2 Cisplatin
0.01
Chemo
Chemotherapy
0.8236 -0.00666
SUM1315MO2 Cisplatin
0.031667
Chemo
Chemotherapy
0.9423 -0.01003
SUM1315MO2 Cisplatin
0.1
Chemo
Chemotherapy
0.7729 0.01389
SUM1315MO2 Cisplatin
0.31623
Chemo
Chemotherapy
0.7794 0.02371
SUM1315MO2 Cisplatin
1.0
Chemo
Chemotherapy
0.5011 0.13135